Osteoporosis and Bone Mass Disorders: From Gene Pathways to Treatments

Harvey, 2010, Osteoporosis: impact on health and economics, Nat. Rev. Rheumatol., 6, 99, 10.1038/nrrheum.2009.260 Vos, 2012, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2163, 10.1016/S0140-6736(12)61729-2 Cooper, 1993, Population-based study of survival after osteoporotic fractures, Am. J. Epidemiol., 137, 1001, 10.1093/oxfordjournals.aje.a116756 Peltonen, 2006, Lessons from studying monogenic disease for common disease, Hum. Mol. Genet., 15, R67, 10.1093/hmg/ddl060 Kryukov, 2009, Power of deep, all-exon resequencing for discovery of human trait genes, Proc. Natl. Acad. Sci. U.S.A., 106, 3871, 10.1073/pnas.0812824106 Duncan, 2014, The revolution in human monogenic disease mapping, Genes, 5, 792, 10.3390/genes5030792 Ng, 2010, Exome sequencing identifies the cause of a mendelian disorder, Nat. Genet., 42, 30, 10.1038/ng.499 Lohmueller, 2003, Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease, Nat. Genet., 33, 177, 10.1038/ng1071 Ehret, 2011, Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk, Nature, 478, 103, 10.1038/nature10405 Lango Allen, 2010, Hundreds of variants clustered in genomic loci and biological pathways affect human height, Nature, 467, 832, 10.1038/nature09410 Teslovich, 2010, Biological, clinical and population relevance of 95 loci for blood lipids, Nature, 466, 707, 10.1038/nature09270 Ioannidis, 2006, A road map for efficient and reliable human genome epidemiology, Nat. Genet., 38, 3, 10.1038/ng0106-3 Gusev, 2014, Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases, Am. J. Hum. Genet., 95, 535, 10.1016/j.ajhg.2014.10.004 Baylink, 1993, Growth factors to stimulate bone formation, J. Bone Miner. Res., 8, S565 Weaver, 2016, The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations, Osteoporos. Int. Seeman, 2006, Bone quality — the material and structural basis of bone strength and fragility, N. Engl. J. Med., 354, 2250, 10.1056/NEJMra053077 Tanaka, 2005, Osteoblasts and osteoclasts in bone remodeling and inflammation, Curr. Drug Targets Inflamm. Allergy, 4, 325, 10.2174/1568010054022015 Bonewald, 2011, The amazing osteocyte, J. Bone Miner. Res., 26, 229, 10.1002/jbmr.320 Raisz, 2005, Pathogenesis of osteoporosis: concepts, conflicts, and prospects, J. Clin. Invest., 115, 3318, 10.1172/JCI27071 Zhang, 2010, Proteomics in bone research, Expert Rev. Proteomics, 7, 103, 10.1586/epr.09.90 Rasmussen, 1974, Hormonal control of skeletal and mineral homeostasis, Am. J. Med., 56, 751, 10.1016/0002-9343(74)90802-X Mohan, 1991, Bone growth factors, Clin. Orthop. Relat. Res., 1991, 30 Cheng, 2010, SOX9 determines RUNX2 transactivity by directing intracellular degradation, J. Bone Miner. Res., 25, 2680, 10.1002/jbmr.174 Lian, 2006, Networks and hubs for the transcriptional control of osteoblastogenesis, Rev. Endocr. Metab. Disord., 7, 1, 10.1007/s11154-006-9001-5 Yang, 2002, Transcription factors in bone: developmental and pathological aspects, Trends Mol. Med., 8, 340, 10.1016/S1471-4914(02)02340-7 Woodgett, 1990, Molecular cloning and expression of glycogen synthase kinase-3/factor A, EMBO J., 9, 2431, 10.1002/j.1460-2075.1990.tb07419.x Bafico, 2001, Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow, Nat. Cell Biol., 3, 683, 10.1038/35083081 Sato, 2004, Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor, Nat. Med., 10, 55, 10.1038/nm979 Regan, 2013, Notch signaling and bone remodeling, Curr. Osteoporos. Rep., 11, 126, 10.1007/s11914-013-0145-4 Kopan, 2009, The canonical Notch signaling pathway: unfolding the activation mechanism, Cell, 137, 216, 10.1016/j.cell.2009.03.045 Espinosa, 2003, Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways, J. Biol. Chem., 278, 32227, 10.1074/jbc.M304001200 Foltz, 2002, Glycogen synthase kinase-3beta modulates notch signaling and stability, Curr. Biol., 12, 1006, 10.1016/S0960-9822(02)00888-6 Kwon, 2011, Notch post-translationally regulates beta-catenin protein in stem and progenitor cells, Nat. Cell Biol., 13, 1244, 10.1038/ncb2313 Yang, 2015, The Hedgehog signalling pathway in bone formation, Int. J. Oral Sci., 7, 73, 10.1038/ijos.2015.14 Thorogood, 1975, An analysis of the condensation process during chondrogenesis in the embryonic chick hind limb, J. Embryol. Exp. Morphol., 33, 581 Mak, 2006, Wnt/beta-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation, Development, 133, 3695, 10.1242/dev.02546 Tian, 2012, Osterix is required for Sonic hedgehog-induced osteoblastic MC3T3-E1 cell differentiation, Cell Biochem. Biophys., 64, 169, 10.1007/s12013-012-9369-7 Mak, 2008, Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression, Dev. Cell, 14, 674, 10.1016/j.devcel.2008.02.003 Amano, 2014, Indian hedgehog signaling regulates transcription and expression of collagen type X via Runx2/Smads interactions, J. Biol. Chem., 289, 24898, 10.1074/jbc.M114.570507 Boyce, 2007, Biology of RANK, RANKL, and osteoprotegerin, Arthritis Res. Ther., 9, S1, 10.1186/ar2165 Glass, 2005, Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation, Dev. Cell, 8, 751, 10.1016/j.devcel.2005.02.017 Bonafe, 2015, Nosology and classification of genetic skeletal disorders: 2015 revision, Am. J. Med. Genet. A, 167, 2869, 10.1002/ajmg.a.37365 Forlino, 2015, Osteogenesis imperfecta, Lancet Gong, 2001, LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development, Cell, 107, 513, 10.1016/S0092-8674(01)00571-2 Laine, 2013, WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta, N. Engl. J. Med., 368, 1809, 10.1056/NEJMoa1215458 Boyden, 2002, High bone density due to a mutation in LDL-receptor-related protein 5, N. Engl. J. Med., 346, 1513, 10.1056/NEJMoa013444 van Dijk, 2013, PLS3 mutations in X-linked osteoporosis with fractures, N. Engl. J. Med., 369, 1529, 10.1056/NEJMoa1308223 Millan, 2016, Alkaline phosphatase and hypophosphatasia, Calcif. Tissue Int., 31, 173 2007, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, 447, 661, 10.1038/nature05911 Klein, 2005, Complement factor H polymorphism in age-related macular degeneration, Science, 308, 385, 10.1126/science.1109557 Wang, 2005, Genome-wide association studies: theoretical and practical concerns, Nat. Rev. Genet., 6, 109, 10.1038/nrg1522 Ioannidis, 2005, Why most published research findings are false, PLoS Med., 2, e124, 10.1371/journal.pmed.0020124 Ioannidis, 2004, Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes, JAMA, 292, 2105, 10.1001/jama.292.17.2105 Uitterlinden, 2006, The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis, Ann. Intern. Med., 145, 255, 10.7326/0003-4819-145-4-200608150-00005 Ralston, 2006, Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study, PLoS Med., 3, e90, 10.1371/journal.pmed.0030090 Langdahl, 2008, Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study, Bone, 42, 969, 10.1016/j.bone.2007.11.007 van Meurs, 2008, Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis, JAMA, 299, 1277, 10.1001/jama.299.11.1277 Visscher, 2012, Five years of GWAS discovery, Am. J. Hum. Genet., 90, 7, 10.1016/j.ajhg.2011.11.029 Stranger, 2011, Progress and promise of genome-wide association studies for human complex trait genetics, Genetics, 187, 367, 10.1534/genetics.110.120907 Welter, 2014, The NHGRI GWAS Catalog, a curated resource of SNP–trait associations, Nucleic Acids Res., 42, D1001, 10.1093/nar/gkt1229 Yang, 2010, Common SNPs explain a large proportion of the heritability for human height, Nat. Genet., 42, 565, 10.1038/ng.608 Yang, 2011, Genome partitioning of genetic variation for complex traits using common SNPs, Nat. Genet., 43, 519, 10.1038/ng.823 Yang, 2015, Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index, Nat. Genet., 47, 1114, 10.1038/ng.3390 Chatterjee, 2013, Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies, Nat. Genet., 45, 400, 10.1038/ng.2579 Park, 2010, Estimation of effect size distribution from genome-wide association studies and implications for future discoveries, Nat. Genet., 42, 570, 10.1038/ng.610 Tennessen, 2012, Evolution and functional impact of rare coding variation from deep sequencing of human exomes, Science, 337, 64, 10.1126/science.1219240 The International HapMap Project, 2003, Nature, 426, 789, 10.1038/nature02168 Zheng, 2012, WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk, PLoS Genet., 8, e1002745, 10.1371/journal.pgen.1002745 Styrkarsdottir, 2009, New sequence variants associated with bone mineral density, Nat. Genet., 41, 15, 10.1038/ng.284 Styrkarsdottir, 2008, Multiple genetic loci for bone mineral density and fractures, N. Engl. J. Med., 358, 2355, 10.1056/NEJMoa0801197 Rivadeneira, 2009, Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies, Nat. Genet., 41, 1199, 10.1038/ng.446 Richards, 2008, Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, Lancet, 371, 1505, 10.1016/S0140-6736(08)60599-1 Richards, 2009, Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture, Ann. Intern. Med., 151, 528, 10.7326/0003-4819-151-8-200910200-00006 Paternoster, 2010, OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon Longitudinal Study of Parents and Children and Gothenburg Osteoporosis and Obesity Determinants Cohorts, J. Clin. Endocrinol. Metab., 95, 3940, 10.1210/jc.2010-0025 Paternoster, 2010, Genome-wide association meta-analysis of cortical bone mineral density unravels allelic heterogeneity at the RANKL locus and potential pleiotropic effects on bone, PLoS Genet., 6, e1001217, 10.1371/journal.pgen.1001217 Ohlsson, 2011, Genetic determinants of serum testosterone concentrations in men, PLoS Genet., 7, e1002313, 10.1371/journal.pgen.1002313 Oei, 2014, Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus, Bone, 59, 20, 10.1016/j.bone.2013.10.015 Moayyeri, 2014, Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium, Hum. Mol. Genet., 23, 3054, 10.1093/hmg/ddt675 Medina-Gomez, 2012, Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus, PLoS Genet., 8, e1002718, 10.1371/journal.pgen.1002718 Liu, 2013, Assessment of gene-by-sex interaction effect on bone mineral density, J. Bone Miner. Res., 27, 2051, 10.1002/jbmr.1679 Estrada, 2012, Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture, Nat. Genet., 44, 491, 10.1038/ng.2249 Duncan, 2011, Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk, PLoS Genet., 7, e1001372, 10.1371/journal.pgen.1001372 Schuit, 2004, Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study, Bone, 34, 195, 10.1016/j.bone.2003.10.001 Raychaudhuri, 2011, VIZ-GRAIL: visualizing functional connections across disease loci, Bioinformatics, 27, 1589, 10.1093/bioinformatics/btr185 Topaz, 2004, Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis, Nat. Genet., 36, 579, 10.1038/ng1358 Scott, 1993, Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes, Am. J. Hum. Genet., 53, 973 Vallet, 2015, Targeted sequencing of the Paget's disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget's disease of bone, Hum. Mol. Genet., 24, 3286, 10.1093/hmg/ddv068 Mundlos, 1997, Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia, Cell, 89, 773, 10.1016/S0092-8674(00)80260-3 Moffatt, 2013, Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2, Am. J. Hum. Genet., 92, 252, 10.1016/j.ajhg.2012.12.001 Smith, 1994, Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man, N. Engl. J. Med., 331, 1056, 10.1056/NEJM199410203311604 Lamande, 1989, Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta, J. Biol. Chem., 264, 15809, 10.1016/S0021-9258(18)71548-2 Crackower, 1996, Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development, Hum. Mol. Genet., 5, 571, 10.1093/hmg/5.5.571 Whyte, 2002, Osteoprotegerin deficiency and juvenile Paget's disease, N. Engl. J. Med., 347, 175, 10.1056/NEJMoa013096 Li, 2010, LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani–Lenz syndrome, Am. J. Hum. Genet., 86, 696, 10.1016/j.ajhg.2010.03.004 Leupin, 2011, Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function, J. Biol. Chem., 286, 19489, 10.1074/jbc.M110.190330 Styrkarsdottir, 2013, Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits, Nature, 497, 517, 10.1038/nature12124 Lapunzina, 2010, Identification of a frameshift mutation in osterix in a patient with recessive osteogenesis imperfecta, Am. J. Hum. Genet., 87, 110, 10.1016/j.ajhg.2010.05.016 Cleiren, 2001, Albers–Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene, Hum. Mol. Genet., 10, 2861, 10.1093/hmg/10.25.2861 Kornak, 2001, Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man, Cell, 104, 205, 10.1016/S0092-8674(01)00206-9 Brunkow, 2001, Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein, Am. J. Hum. Genet., 68, 577, 10.1086/318811 Balemans, 2002, Identification of a 52kb deletion downstream of the SOST gene in patients with van Buchem disease, J. Med. Genet., 39, 91, 10.1136/jmg.39.2.91 Foster, 1994, Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene, Nature, 372, 525, 10.1038/372525a0 Hughes, 2000, Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis, Nat. Genet., 24, 45, 10.1038/71667 Guerrini, 2008, Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations, Am. J. Hum. Genet., 83, 64, 10.1016/j.ajhg.2008.06.015 Kemp, 2014, Phenotypic dissection of bone mineral density reveals skeletal site specificity and facilitates the identification of novel loci in the genetic regulation of bone mass attainment, PLoS Genet., 10, e1004423, 10.1371/journal.pgen.1004423 Styrkarsdottir, 2015, Two rare mutations in the COL1A2 gene associate with low bone mineral density and fractures in Iceland, J. Bone Miner. Res., 31, 173, 10.1002/jbmr.2604 Koller, 2013, Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPS associated with bone mineral density in premenopausal women, J. Bone Miner. Res., 28, 547, 10.1002/jbmr.1796 Moayyeri, 2009, The effect of including quantitative heel ultrasound in models for estimation of 10-year absolute risk of fracture, Bone, 45, 180, 10.1016/j.bone.2009.05.001 Moverare-Skrtic, 2014, Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures, Nat. Med., 20, 1279, 10.1038/nm.3654 Moverare-Skrtic, 2015, The bone-sparing effects of estrogen and WNT16 are independent of each other, Proc. Natl. Acad. Sci. U.S.A., 112, 14972, 10.1073/pnas.1520408112 Cooper, 2006, Review: developmental origins of osteoporotic fracture, Osteoporos Int., 17, 337, 10.1007/s00198-005-2039-5 Ferrari, 1998, Familial resemblance for bone mineral mass is expressed before puberty, J. Clin. Endocrinol. Metab., 83, 358 Jaddoe, 2012, The Generation R Study: design and cohort update 2012, Eur. J. Epidemiol., 27, 739, 10.1007/s10654-012-9735-1 Hui, 1990, The contribution of bone loss to postmenopausal osteoporosis, Osteoporos Int., 1, 30, 10.1007/BF01880413 Finkelstein, 2002, Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors, J. Clin. Endocrinol. Metab., 87, 3057, 10.1210/jcem.87.7.8654 Marshall, 2008, Race and ethnic variation in proximal femur structure and BMD among older men, J. Bone Miner. Res., 23, 121, 10.1359/jbmr.070908 Thandrayen, 2009, Fracture rates in urban South African children of different ethnic origins: the Birth to Twenty cohort, Osteoporos Int., 20, 47, 10.1007/s00198-008-0627-x Wren, 2012, Racial disparity in fracture risk between white and nonwhite children in the United States, J. Pediatr., 161, 1035, 10.1016/j.jpeds.2012.07.054 Medina-Gomez, 2015, BMD loci contribute to ethnic and developmental differences in skeletal fragility across populations: assessment of evolutionary selection pressures, Mol. Biol. Evol., 32, 2961, 10.1093/molbev/msv170 Zemel, 2011, Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study, J. Clin. Endocrinol. Metab., 96, 3160, 10.1210/jc.2011-1111 Bhudhikanok, 1996, Differences in bone mineral in young Asian and Caucasian Americans may reflect differences in bone size, J. Bone Miner. Res., 11, 1545, 10.1002/jbmr.5650111023 Styrkarsdottir, 2016, Sequence variants in the PTCH1 gene associate with spine bone mineral density and osteoporotic fractures, Nat. Commun., 7, 10129, 10.1038/ncomms10129 Zheng, 2015, Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture, Nature, 526, 112, 10.1038/nature14878 Adamska, 2004, En1 and Wnt7a interact with Dkk1 during limb development in the mouse, Dev. Biol., 272, 134, 10.1016/j.ydbio.2004.04.026 Richards, 2012, Genetics of osteoporosis from genome-wide association studies: advances and challenges, Nat. Rev. Genet., 13, 576, 10.1038/nrg3228 Lewiecki, 2010, Treatment of osteoporosis with denosumab, Maturitas, 66, 182, 10.1016/j.maturitas.2010.02.008 Saini, 2013, Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH, J. Biol. Chem., 288, 20122, 10.1074/jbc.M112.441360 Horwitz, 2013, A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study, J. Bone Miner. Res., 28, 2266, 10.1002/jbmr.1978 Tsai, 2013, Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial, Lancet, 382, 50, 10.1016/S0140-6736(13)60856-9 Kang, 2014, New insights into Wnt-Lrp5/6-beta-catenin signaling in mechanotransduction, Front. Endocrinol., 5, p246 Recker, 2015, A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density, J. Bone Miner. Res., 30, 216, 10.1002/jbmr.2351 Compton, 2014, A review of osteocyte function and the emerging importance of sclerostin, J. Bone Joint Surg. Am., 96, 1659, 10.2106/JBJS.M.01096 McColm, 2014, Single- and multiple-dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women, J. Bone Miner. Res., 29, 935, 10.1002/jbmr.2092 Padhi, 2014, Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study, J. Clin. Pharmacol., 54, 168, 10.1002/jcph.239 Ahmed, 2015, Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures, Osteoporos. Int., 26, 2137, 10.1007/s00198-015-3118-x Chen, 2012, Antiresorptive therapies for osteoporosis: a clinical overview, Nat. Rev. Endocrinol., 8, 81, 10.1038/nrendo.2011.146 Nelson, 2015, The support of human genetic evidence for approved drug indications, Nat. Genet., 47, 856, 10.1038/ng.3314